Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Thomas Ebeling
10 Jun 2024
Director
Exercised, kept
18,450
$13.00
$239.85K
Morana Jovan-Embiricos
24 Jun 2022
10% owner
Exercised, kept
35,529
$4.30
$152.77K
Morana Jovan-Embiricos
24 Jun 2022
10% owner
Exercised, kept
104,845
$4.30
$450.83K

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 34
Sales at will 139
Transactions with no price 0
Shares from compensation/vesting 31,067,955
Sales filed before the plan box existed 81
History held since 11 Jan 2021